CTRI/2012/09/003000已完成4 期
A Randomized, open label, comparative, parallel group, three-arm study to evaluate the efficacy, safety and tolerability ofa combination of clobetasol, neomycin and miconazole versus combination of betamethasone, clotrimazole, neomycin versus combination of betamethasone, gentamicin, miconazole in patients with any type of eczematous disorderassociated with underlying tinea / yeast infection
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 54
- 试验地点
- 1
- 主要终点
- •Improvement in clinical score from baseline
研究概览
简要总结
This study is done to evaluated the efficacy and safety of a combination of clobetasol, neomycin and miconazole versus combination of betamethasone, clotrimazole, neomycin versus combination of betamethasone, gentamicin, miconazole in patients with any type of eczematous disorder associated with underlying tinea / yeast infectionxml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /
研究设计
- 研究类型
- Interventional
- 分配方式
- Permuted block randomization, fixed
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •â€¢Patients aged 18 years and above diagnosed with any type of eczematous disorder associated presenting clinical features of underlying tinea/yeast infection •Patients who agree to adhere to the study design •Patients who give their consent for participation in this study.
排除标准
- •â€¢Pregnant or lactating females •Indications for use of systemic therapy •Patients sensitive to corticosteroids •Patients who have immune deficiency, hepatic or renal impairment •Patients who have been on any therapy within 1 month prior to enrollment in the study •Patients who are using any other concomitant therapy.
结局指标
主要结局
•Improvement in clinical score from baseline
时间窗: Baseline, Day3, Day5 and Day7
次要结局
- •Improvement in scaling and inflammation(•Improvement in burning and itching)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Clinical Trial to Investigate the Efficacy and Safety of DWJ1351HealthyNCT03753477Daewoong Pharmaceutical Co. LTD.64
Unknown
1 期
Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy SubjectsHealthyNCT03016494Daewoong Pharmaceutical Co. LTD.56
已完成
不适用
Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel SyndromeConstipation-predominant Irritable Bowel SyndromeNCT00945334Mark Pimentel, MD37
Unknown
3 期
Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)Diffuse Large B-cell LymphomaNCT03777085Chia Tai Tianqing Pharmaceutical Group Co., Ltd.230
已完成
3 期
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)OsteoarthritisNCT00092352Merck Sharp & Dohme LLC395